Sentence examples for assay disclosed from inspiring English sources

The CUPRAC assay disclosed that compound 2 displayed better activity than α-tocopherol.

The scratch assay disclosed an enhanced ovarian cancer cell migration at 12 and 24 hours post-addition of platelets.

Dopamine-induced enhancement of WM performance was accompanied by significant changes in MEG signal power, and a DCM assay disclosed related changes in synaptic signaling.

Hoechst 33258 staining and flow cytometry assay disclosed that the fraction of nucleic fragmentation and sub-G1 phase of T24 sphere cells raised significantly after OncoAd.RGD-hTERT-TRAIL treatment.

The results obtained from platinum accumulation assay disclosed that cellular concentration of CDDP and oxaliplatin decreased by about 35 and 12%, respectively, in S3 cells when compared to parental TSGH cells.

The results demonstrated that repeated testing (three replicates of all scalar dilutions tested) of our assay disclosed 10 HTLV-I equivalent genome copies in 100% of replicates (Table 2), whereas a positive signal was not always detected when five copies were assayed in our experimental conditions.

Bioinformatic analysis and DNA protein binding assays disclosed three active Sp1 sites (−19/27, −61/69 and −82/89) in Prdx6 promoter.

In 25 normal post-menopausal and in 27 post-menopausal women with cancer repeated assays disclosed consistently low levels of oestradiol-17β.

Their in vitro antitumor activities were tested by the standard MTT assay which disclosed that compound 33 (IC50 = 0.28 0.52 μM) showed potential antitumor activities.

As shown in Fig. 1, when distinguishing aPL+ patients based on LAC assay, LAC+ disclosed higher PAF-AH than LAC-negative patients (22.1 ± 6.4 nmol/min/ml vs. 19.5 ± 4.1 nmol/min/ml; p = 0.0032).

Cr-released assays also disclosed the similar lytic pattern of rat TIL against autologous and allogeneic tumor cell lines (UMR 106, ROS 17/2.8) to human TIL.